Kartarius S - Search Results

1

Detailed chromosomal characterization of the breast cancer cell line MCF7 with special focus on the expression of the serine-threonine kinase 15.

Klein A, Jung V, Zang KD, Henn W, Montenarh M, Kartarius S, Steudel WI, Urbschat S. Klein A, et al. Among authors: kartarius s. Oncol Rep. 2005 Jul;14(1):23-31. Oncol Rep. 2005. PMID: 15944763

2

Cyclin H is a new binding partner for protein kinase CK2.

Faust M, Kartarius S, Schwindling SL, Montenarh M. Faust M, et al. Among authors: kartarius s. Biochem Biophys Res Commun. 2002 Aug 9;296(1):13-9. doi: 10.1016/s0006-291x(02)00825-2. Biochem Biophys Res Commun. 2002. PMID: 12147220

3

Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein.

Götz C, Kartarius S, Schwär G, Montenarh M. Götz C, et al. Among authors: kartarius s. Int J Oncol. 2005 Mar;26(3):801-8. Int J Oncol. 2005. PMID: 15703839

4

Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.

Götz C, Kartarius S, Schetting S, Montenarh M. Götz C, et al. Among authors: kartarius s. Mol Cell Biochem. 2005 Jun;274(1-2):181-7. doi: 10.1007/s11010-005-2950-2. Mol Cell Biochem. 2005. PMID: 16335537

5

The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H.

Schneider E, Kartarius S, Schuster N, Montenarh M. Schneider E, et al. Among authors: kartarius s. Oncogene. 2002 Aug 1;21(33):5031-7. doi: 10.1038/sj.onc.1205690. Oncogene. 2002. PMID: 12140753

6

Growth inhibition and apoptosis induction in ovarian cancer cells.

Touma R, Kartarius S, Harlozinska A, Götz C, Montenarh M. Touma R, et al. Among authors: kartarius s. Int J Oncol. 2006 Aug;29(2):481-8. Int J Oncol. 2006. PMID: 16820892

7

p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.

Montenarh M, Harloziñska A, Bar JK, Kartarius S, Günther J, Sedlaczek P. Montenarh M, et al. Among authors: kartarius s. Int J Oncol. 1998 Sep;13(3):605-10. doi: 10.3892/ijo.13.3.605. Int J Oncol. 1998. PMID: 9683801

8

Immunologically defined subclasses of the growth suppressor protein p53 detected with antibodies in sera from tumor patients.

Hoher D, Kartarius S, Porzsolt F, Montenarh M. Hoher D, et al. Among authors: kartarius s. Int J Oncol. 1993 Oct;3(4):741-7. doi: 10.3892/ijo.3.4.741. Int J Oncol. 1993. PMID: 21573427

9

Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.

Harlozinska A, Bar JK, Montenarh M, Kartarius S. Harlozinska A, et al. Among authors: kartarius s. Oncol Rep. 2002 Nov-Dec;9(6):1173-9. Oncol Rep. 2002. PMID: 12375014

10

Two different forms of p53 localized differently within cells of urogenital tumours.

Benninghoff J, Kartarius S, Teleb Z, Selter H, Unteregger G, Zwergel T, Wullich B, Montenarh M. Benninghoff J, et al. Among authors: kartarius s. Cancer Lett. 1999 Sep 20;144(1):55-64. doi: 10.1016/s0304-3835(99)00187-1. Cancer Lett. 1999. PMID: 10503878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters